Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature
- PMID: 24527242
- PMCID: PMC3914170
- DOI: 10.1155/2013/124604
Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature
Abstract
Orlistat is a gastrointestinal lipase inhibitor used for weight reduction in obese individuals. Enteric hyperoxaluria caused by orlistat leads to oxalate absorption. Acute oxalate nephropathy is a rare complication of treatment with orlistat. Herein we report a patient presenting with acute renal failure which improved minimal with intravenous hydration. She was found to have oxalate crystals on renal biopsy. Patient admitted orlistat use over the counter for weight reduction on further questioning. The purpose of this case review is to increase awareness among patients since they are more focused on losing weight. This case also calls for the provider attention to educate patients regarding side effects of orlistat because of easy availability of orlistat over the counter.
Figures
References
-
- Winearls CG. Iatrogenic acute oxalate nephropathy. Nephrology, Dialysis, Transplantation. 1995;10(12):p. 2171. - PubMed
-
- Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate nephropathy after ingestion of star fruit. American Journal of Kidney Diseases. 2001;37(2):418–422. - PubMed
-
- Keiran S, Bhimani B, Dixit A. Ethylene glycol toxicity. American Journal of Kidney Diseases. 2005;46(3):e31–e33. - PubMed
-
- Ahmed MH. Orlistat and calcium oxalate crystalluria: an association that needs consideration. Renal Failure. 2010;32(8):1019–1021. - PubMed
-
- Singh A, Sarkar SR, Gaber LW, Perazella MA. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. American Journal of Kidney Diseases. 2007;49(1):153–157. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
